Protalix BioTherapeutics, Inc. ( PLX) - Key Metrics
PLX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.12 | -$0.07 | $0.03 | $0.04 |
| 2025Q3 | $0.23 | $0.03 | -$0.05 | -$0.05 |
| 2025Q2 | $0.20 | $0 | -$0.07 | -$0.07 |
| 2025Q1 | $0.13 | -$0.05 | -$0.07 | -$0.07 |
PLX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -6.42 |
| 2025Q3 | ? | 18.68 |
| 2025Q2 | ? | 177.47 |
| 2025Q1 | ? | -13.55 |
PLX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 12.27% | ? |
| 2025Q4 | 2.31% | ? |
| 2025Q3 | -2.40% | ? |
| 2025Q2 | -4.87% | ? |
| 2025Q1 | -2.73% | ? |
PLX
Price: $2.01
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 10.05
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 637200
Market Capitalization: 153.9 million